MRNA Starts 2026 Volatile: Examining Rally & Pullback, Outsized Options

Moderna (MRNA) experienced a wild start to 2026, with shares nearly doubling before pulling back 20% from the recent 52-week high. Rick Ducat dives into technical trends to watch and the various support and resistance levels in the stock chart. As for the options flow, Rick talks about the massively outsized move traders experienced Friday.

Market On Close

13 Feb 2026

SHARE

Schwab Network's Newsletters

Daily insights for every investor

ON AIR
4:30 pm
Market On Close
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
2:00 am
Market Overtime
REPLAY
2:30 am
Market Overtime
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
education
5:00 am
Liz Ann Live
REPLAY
5:30 am
The Wrap
REPLAY
education
7:00 am
Schwab 2026 Outlook
REPLAY
8:00 am
Market Overtime
REPLAY
8:30 am
Market On Close
REPLAY
10:00 am
Market Overtime
REPLAY
10:30 am
Market Overtime
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Liz Ann Live
REPLAY
1:30 pm
The Wrap
REPLAY
education
3:00 pm
Schwab 2026 Outlook
REPLAY
4:00 pm
Market Overtime
REPLAY
ON AIR
4:30 pm
Market On Close
REPLAY
6:00 pm
Market Overtime
REPLAY
6:30 pm
Market Overtime
REPLAY
7:00 pm
Fast Market
REPLAY
8:00 pm
Next Gen Investing
REPLAY
education
9:00 pm
Liz Ann Live
REPLAY
9:30 pm
The Wrap
REPLAY
education
11:00 pm
Schwab 2026 Outlook
REPLAY